Medicine details
Image | |
Name | Aldes 400 |
Dosage | Tablet |
Generic Name | Albendazole |
Classes |
Antiinfective Agent Anthelmintic/Antiparasitic |
Diseases |
Diarrhea Dizziness Infectious Disease Nausea Stomach Pain Vomiting |
Company | Desh Pharmaceuticals Ltd. |
Drug Package Details
Strength | 400 mg |
Storage Condition | |
Origin Country | Bangladesh |
Commercial Pack | 50 |
Price per pack | ৳ 150.00 |
Cost per pack | ৳ 132.00 |
Package unit | 10 tabs strip |
Price per unit | ৳ 3.00 |
Cost per unit | ৳ 2.64 |
Discount | 0 |
Coupon | |
Remarks |
Albendazole
Albendazole is an orally administered broad-spectrum anthelmintic. Albendazole, as a vermicide, produces degenerative changes in the worm's intestinal cells by binding to the colchicine-sensitive region of -tubulin, preventing it from polymerizing or assembling into microtubules.
Hydatid Disease:
- 60 kg or greater: 400 mg twice daily, with meals in 28-day cycle followed by a 14-day albendazole-free interval, for a total of 3 cycles
- less than 60 kg: 15 mg/kg/day given in divided doses twice daily with meals (maximum total daily dose 800 mg), in 28-day cycle followed by a 14-day albendazole-free interval, for a total of 3 cycles
Neurocysticercosis:
- 60 kg or greater: 400 mg twice daily, with meals for 8-30 days.
- 15 mg/kg/day given in divided doses twice daily with meals (maximum total daily dose 800 mg) for 8-30 days.
- Patients with neurocysticercosis should be treated with steroid and anticonvulsant medications as needed. During the first week of anticysticeral medication, oral or intravenous corticosteroids should be taken to prevent cerebral hypertension events.
- Patients treated with albendazole for other illnesses may also be found to have pre-existing neurocysticercosis. As a result of an inflammatory reaction triggered by the parasite's demise within the brain, patients may develop neurological symptoms (e.g. seizures, elevated intracranial pressure, and localized signs). Symptoms may appear soon after treatment; steroid and anticonvulsant medication should be started as away.
- Rare fatalities associated with the use of albendazole have been reported due to granulocytopenia or pancytopenia. Albendazole has been shown to cause bone marrow suppression, aplastic anemia, and agranulocytosis in patients with and without underlying hepatic dysfunction.
Contraindication
Contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds or any components of the medications.
There's no known contraindications of albendazole in terms of food and drinks.
Albendazole should only be administered in pregnant women if no other treatment options are available. Following the discontinuation of albendazole therapy, patients should not become pregnant for at least one month. Albendazole should be stopped immediately if a patient falls pregnant while taking it.